Mead Johnson Nutrition Co. (NYSE:MJN) – Stock analysts at Credit Agricole SA decreased their FY2017 earnings estimates for shares of Mead Johnson Nutrition in a research report issued to clients and investors on Tuesday. Credit Agricole SA analyst M. Lavery now expects that the firm will post earnings per share of $3.45 for the year, down from their prior estimate of $3.60. Credit Agricole SA has a “Underperform” rating and a $77.00 price target on the stock.

Mead Johnson Nutrition (NYSE:MJN) last announced its quarterly earnings data on Thursday, October 27th. The company reported $0.87 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.01. Mead Johnson Nutrition had a negative return on equity of 119.05% and a net margin of 13.26%. The business had revenue of $937.50 million for the quarter, compared to the consensus estimate of $933.43 million. During the same period in the previous year, the business earned $0.77 earnings per share. The business’s revenue was down 4.1% on a year-over-year basis.

Earnings History and Estimates for Mead Johnson Nutrition (NYSE:MJN)

Other equities analysts have also issued research reports about the company. Credit Suisse Group AG set a $100.00 target price on Mead Johnson Nutrition and gave the stock a “buy” rating in a research note on Monday, September 12th. Citigroup Inc. reduced their target price on Mead Johnson Nutrition from $106.00 to $103.00 and set a “buy” rating for the company in a research note on Thursday, September 8th. Deutsche Bank AG set a $88.00 target price on Mead Johnson Nutrition and gave the stock a “hold” rating in a research note on Sunday, July 24th. Societe Generale lowered Mead Johnson Nutrition from a “buy” rating to a “hold” rating and reduced their target price for the stock from $100.00 to $95.00 in a research note on Friday, July 29th. Finally, Susquehanna restated a “hold” rating and issued a $90.00 target price on shares of Mead Johnson Nutrition in a research note on Wednesday, September 7th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $88.33.

Mead Johnson Nutrition (NYSE:MJN) opened at 71.00 on Friday. The stock has a 50 day moving average price of $77.51 and a 200 day moving average price of $83.46. Mead Johnson Nutrition has a 12 month low of $65.53 and a 12 month high of $94.40. The stock has a market capitalization of $13.12 billion, a P/E ratio of 26.38 and a beta of 1.43.

In other news, Director Anna C. Catalano sold 656 shares of the firm’s stock in a transaction dated Monday, October 31st. The stock was sold at an average price of $74.99, for a total transaction of $49,193.44. Following the sale, the director now directly owns 8,796 shares in the company, valued at approximately $659,612.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.50% of the company’s stock.

Large investors have recently bought and sold shares of the stock. William Blair Investment Management LLC acquired a new stake in Mead Johnson Nutrition during the second quarter worth approximately $142,077,000. Nordea Investment Management AB boosted its stake in Mead Johnson Nutrition by 3.7% in the second quarter. Nordea Investment Management AB now owns 609,915 shares of the company’s stock worth $55,350,000 after buying an additional 22,012 shares during the period. DUPONT CAPITAL MANAGEMENT Corp boosted its stake in Mead Johnson Nutrition by 88.4% in the second quarter. DUPONT CAPITAL MANAGEMENT Corp now owns 138,066 shares of the company’s stock worth $12,529,000 after buying an additional 64,766 shares during the period. Ngam Advisors L.P. boosted its stake in Mead Johnson Nutrition by 14.0% in the second quarter. Ngam Advisors L.P. now owns 132,485 shares of the company’s stock worth $12,023,000 after buying an additional 16,320 shares during the period. Finally, Sensato Investors LLC acquired a new stake in Mead Johnson Nutrition during the first quarter worth approximately $13,841,000. Hedge funds and other institutional investors own 98.73% of the company’s stock.

About Mead Johnson Nutrition

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Receive News & Stock Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related stocks with our FREE daily email newsletter.